SPYRE THERAPEUTICS, INC. Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss
SPYRE THERAPEUTICS, INC. (SYRE) had Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss of $34.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-02.
Discontinued › Notes › ASU 2016-13 Transition
us-gaap:HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss · last filed 2023-03-02
- 2022-12-31: Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss $34.00K.
- 2022-09-30: Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss $116.00K.
- 2022-06-30: Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss $190.00K.
- 2022-03-31: Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss $158.00K.
| Period end | Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss |
|---|---|
| 2022-12-31 | $34.00K 10-K · filed 2023-03-02 |
| 2022-09-30 | $116.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $190.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $158.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $41.00K 10-K · filed 2023-03-02 |
| 2020-12-31 | $10.00K 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |